[ [link removed] ]Katie Porter for Senate



This week the Biden Administration announced ten commonly used drugs that
Medicare will now be able to negotiate the price of.

While this is great news for American taxpayers and patients, Big Pharma
isn’t happy.

[ [link removed] ]A headline from Politico detailing Big Pharma's pushback to Medicare
drug price negotiations.

Big Pharma is bringing lawsuits to courts across the country to try and
curb Medicare’s ability to negotiate prices. And they’re continuing to
mislead the public about what these negotiations mean. One of their
favorite myths to spread is that lowering costs will stifle research and
development of new treatments.

I’ve proven the opposite is true. Big Pharma companies are the ones who
curb research when they purchase smaller, innovative firms and eliminate
competition. The executives and big shareholders are the only ones who
benefit from this.

I’ve held Big Pharma accountable since coming to Congress in 2019, and
this year my bill to rein in their price-gouging took effect. But there’s
so much more to be done and serious work to do to defend even the bit of
progress we’ve made. Pharmaceutical companies and most Members of Congress
have a strong relationship—but I’m proud to be one of the very few who
doesn’t take money from corporate PACs, federal lobbyists, or Big Pharma
CEOs.

[ [link removed] ]Can you make a contribution today to help send me to the U.S. Senate to
continue holding these corporations accountable and lowering the cost of
lifesaving prescriptions?



[ [link removed] ]Donate ›››



Thanks for your support,

Katie Porter




 


This email was sent to [email protected]. Email is a critical way we communicate with grassroots supporters like you. However, if you would like to change your subscription preferences, here are some options:

Receive Fewer Emails: [link removed]
Update Your Information: [link removed]
Unsubscribe: [link removed]

[PAID FOR BY KATIE PORTER FOR SENATE]